A new publication titled "Surgery on Patients Taking Glucagon-Like Peptide-1 Receptor Agonists" appeared in the journal Advances in Surgery on September 1, 2026. Lixisenatide, an approved glucagon-like peptide-1 receptor agonist, is referenced in connection with this publication. The article is indexed under PubMed ID 42556958.
This brief reports only that the publication exists and that it addresses surgical considerations for patients taking GLP-1 receptor agonists. No specific findings, conclusions, or recommendations from the article are included here, as they were not provided. Readers interested in the full content should consult the journal directly.
Lixisenatide remains an approved compound within the GLP-1 receptor agonist class. This publication adds to the body of literature examining GLP-1 receptor agonists in various clinical contexts, including surgical care. No data on outcomes, safety signals, or efficacy were included in the information available about this publication.
For more background on lixisenatide, including its approved uses and general profile, readers can refer to the compound overview.